Neuropeptides and Alzheimer's disease

M. M. Husain, Charles Nemeroff

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Because of their putative roles as neurotransmitters, neuromodulators, and neuroregulators in the central nervous system, neuropeptides have been the focus of considerable research over the past two decades. There is evidence that alterations in the synaptic availability of particular neuropeptides occur in certain neuropsychiatric disorders, such as schizophrenia and affective disorders. Alzheimer's disease is the most common neurodegenerative disorder, affecting a sizable proportion of our aging population. Alzheimer's disease is characterized by the presence of neurofibrillary tangles and senile plaques in the central nervous system. Postmortem studies have provided evidence that several neuropeptide-containing neurons are pathologically altered in this disorder. The purpose of this article is to describe recent advances in neuropeptide biology with a focus on the role of neuropeptides in the pathogenesis of Alzheimer's disease.

Original languageEnglish
Pages (from-to)918-925
Number of pages8
JournalJournal of the American Geriatrics Society
Volume38
Issue number8
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Neuropeptides
Alzheimer Disease
Neurotransmitter Agents
Central Nervous System
Neurofibrillary Tangles
Amyloid Plaques
Mood Disorders
Neurodegenerative Diseases
Schizophrenia
Neurons
Research
Population

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Neuropeptides and Alzheimer's disease. / Husain, M. M.; Nemeroff, Charles.

In: Journal of the American Geriatrics Society, Vol. 38, No. 8, 01.01.1990, p. 918-925.

Research output: Contribution to journalArticle

@article{5acc43f6365645a8b99267c20ed60a02,
title = "Neuropeptides and Alzheimer's disease",
abstract = "Because of their putative roles as neurotransmitters, neuromodulators, and neuroregulators in the central nervous system, neuropeptides have been the focus of considerable research over the past two decades. There is evidence that alterations in the synaptic availability of particular neuropeptides occur in certain neuropsychiatric disorders, such as schizophrenia and affective disorders. Alzheimer's disease is the most common neurodegenerative disorder, affecting a sizable proportion of our aging population. Alzheimer's disease is characterized by the presence of neurofibrillary tangles and senile plaques in the central nervous system. Postmortem studies have provided evidence that several neuropeptide-containing neurons are pathologically altered in this disorder. The purpose of this article is to describe recent advances in neuropeptide biology with a focus on the role of neuropeptides in the pathogenesis of Alzheimer's disease.",
author = "Husain, {M. M.} and Charles Nemeroff",
year = "1990",
month = "1",
day = "1",
language = "English",
volume = "38",
pages = "918--925",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Neuropeptides and Alzheimer's disease

AU - Husain, M. M.

AU - Nemeroff, Charles

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Because of their putative roles as neurotransmitters, neuromodulators, and neuroregulators in the central nervous system, neuropeptides have been the focus of considerable research over the past two decades. There is evidence that alterations in the synaptic availability of particular neuropeptides occur in certain neuropsychiatric disorders, such as schizophrenia and affective disorders. Alzheimer's disease is the most common neurodegenerative disorder, affecting a sizable proportion of our aging population. Alzheimer's disease is characterized by the presence of neurofibrillary tangles and senile plaques in the central nervous system. Postmortem studies have provided evidence that several neuropeptide-containing neurons are pathologically altered in this disorder. The purpose of this article is to describe recent advances in neuropeptide biology with a focus on the role of neuropeptides in the pathogenesis of Alzheimer's disease.

AB - Because of their putative roles as neurotransmitters, neuromodulators, and neuroregulators in the central nervous system, neuropeptides have been the focus of considerable research over the past two decades. There is evidence that alterations in the synaptic availability of particular neuropeptides occur in certain neuropsychiatric disorders, such as schizophrenia and affective disorders. Alzheimer's disease is the most common neurodegenerative disorder, affecting a sizable proportion of our aging population. Alzheimer's disease is characterized by the presence of neurofibrillary tangles and senile plaques in the central nervous system. Postmortem studies have provided evidence that several neuropeptide-containing neurons are pathologically altered in this disorder. The purpose of this article is to describe recent advances in neuropeptide biology with a focus on the role of neuropeptides in the pathogenesis of Alzheimer's disease.

UR - http://www.scopus.com/inward/record.url?scp=0025002674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025002674&partnerID=8YFLogxK

M3 - Article

C2 - 2201715

AN - SCOPUS:0025002674

VL - 38

SP - 918

EP - 925

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 8

ER -